Tomoki Motegi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tomoki Motegi has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Kazuyuki Uchida
The University of Tokyo, Tokyo, Japan
86 shared publications - Daiki Kato
Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan
85 shared publications - James Kenn Chambers
The University of Tokyo, Tokyo, Japan
85 shared publications - Masahiro Shinada
Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan
85 shared publications - Masaya Tsuboi
Veterinary Medical Center, the University of Tokyo, Tokyo, Japan
85 shared publications - Namiko Ikeda
Laboratory of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan
85 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 301, 111210
A serum-reduced culture system for canine PBMC-derived macrophages enables characterization of M0, M1, and M2 phenotypes and tumor-associated interactions
- 10 September 2026
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 301, 111210
Open AccessA serum-reduced culture system for canine PBMC-derived macrophages enables characterization of M0, M1, and M2 phenotypes and tumor-associated interactions
- Open Access
Benchmarking of local ancestry inference with different assays and parameters
Local ancestry inference (LAI) enables high-resolution characterization of chromosomal segments inherited from distinct ancestral populations, offering unique insights into genetic architecture in admixed cohorts. While LAI is commonly performed with high-coverage whole-genome sequencing (WGS), the ability of other genotyping assays or varying sequencing depths has not been thoroughly benchmarked. In this study, we systematically evaluated the accuracy of LAI across SNP microarrays, whole-exome sequencing (WES), and ultra low-pass WGS (ULP-WGS) using diverse validation samples and state-of-the-art imputation pipelines. We show that ULP-WGS, when paired with GLIMPSE2, achieves robust accuracy at 0.25x coverage with a minimum genome window size of 0.5 centimorgans, with mean accuracy minus one standard deviation exceeding 95%. For WES, using “on-target” reads alone yields suboptimal performance, particularly for European and South Asian ancestries with accuracy less than 79.1% and 70.6%, respectively. However, incorporating “off-target” reads in WES and utilizing GLIMPSE2 substantially improved accuracy ≥95% with a minimum window size of 0.2 centimorgans. We further evaluated formalin-fixed, paraffin-embedded (FFPE) samples and found that LAI could be performed successfully using WES data with accuracies of ≥95% at a minimum window size of 0.5 centimorgans. In contrast, SNP microarrays did not achieve substantial accuracies at any window size (≤95%). Together, these results demonstrate that LAI is achievable without conventional high-coverage WGS and establish optimal parameters for LAI across platforms.
Open AccessBenchmarking of local ancestry inference with different assays and parameters
Local ancestry inference (LAI) enables high-resolution characterization of chromosomal segments inherited from distinct ancestral populations, offering unique insights into genetic architecture in admixed cohorts. While LAI is commonly performed with high-coverage whole-genome sequencing (WGS), the ability of other genotyping assays or varying sequencing depths has not been thoroughly benchmarked. In this study, we systematically evaluated the accuracy of LAI across SNP microarrays, whole-exome sequencing (WES), and ultra low-pass WGS (ULP-WGS) using diverse validation samples and state-of-the-art imputation pipelines. We show that ULP-WGS, when paired with GLIMPSE2, achieves robust accuracy at 0.25x coverage with a minimum genome window size of 0.5 centimorgans, with mean accuracy minus one standard deviation exceeding 95%. For WES, using “on-target” reads alone yields suboptimal performance, particularly for European and South Asian ancestries with accuracy less than 79.1% and 70.6%, respectively. However, incorporating “off-target” reads in WES and utilizing GLIMPSE2 substantially improved accuracy ≥95% with a minimum window size of 0.2 centimorgans. We further evaluated formalin-fixed, paraffin-embedded (FFPE) samples and found that LAI could be performed successfully using WES data with accuracies of ≥95% at a minimum window size of 0.5 centimorgans. In contrast, SNP microarrays did not achieve substantial accuracies at any window size (≤95%). Together, these results demonstrate that LAI is achievable without conventional high-coverage WGS and establish optimal parameters for LAI across platforms.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Canine mucosal melanomas with PDPN high expression demonstrate enrichment of gene signatures associated with amoeboid invasion.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Canine mucosal melanomas with PDPN high expression demonstrate enrichment of gene signatures associated with amoeboid invasion.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Clinical information of dogs used for the survival analysis.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Clinical information of dogs used for the survival analysis.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
ROCK inhibition suppresses features of amoeboid invasion.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
ROCK inhibition suppresses features of amoeboid invasion.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
PDPN promotes tumor growth and amoeboid invasion in vivo.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
PDPN promotes tumor growth and amoeboid invasion in vivo.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Supplementary Materials and Methods
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Supplementary Materials and Methods
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Loss of PDPN leads to cell cycle arrest and cellular senescence.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Loss of PDPN leads to cell cycle arrest and cellular senescence.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Univariate survival analysis of dogs with mucosal melanoma.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Univariate survival analysis of dogs with mucosal melanoma.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Human mucosal melanomas with PDPN high expression demonstrate enrichment of gene signatures associated with amoeboid invasion.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma
Human mucosal melanomas with PDPN high expression demonstrate enrichment of gene signatures associated with amoeboid invasion.